Welcome to our dedicated page for Lakeside Holding SEC filings (Ticker: LSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lakeside Holding Limited (Nasdaq: LSH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Lakeside identifies itself in these filings as a Nevada-incorporated, U.S.-based integrated cross-border supply chain solution provider and emerging growth company whose common stock trades on The Nasdaq Stock Market LLC.
For investors analyzing LSH, key documents include annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe Lakeside’s cross-border freight solutions under the American Bear Logistics brand and its pharmaceutical distribution activities through Hupan Pharmaceutical (Hubei) Co., Ltd. These reports detail revenue composition between third-party and related-party cross-border freight solutions, the contribution from pharmaceutical product distribution, and revenue by customer geographic location.
Current reports on Form 8-K provide timely information about material events, such as the acquisition of Hupan Pharmaceutical, private placements of common stock, convertible debt financings, Nasdaq listing compliance notices, and changes in directors and executive officers. An 8-K also documents that Lakeside’s common stock is listed on Nasdaq under the symbol LSH and that the company is treated as an emerging growth company. Notifications of late filing on Form 12b-25 (NT 10-Q) explain any delays in quarterly report submissions and the expected timing of those filings.
Lakeside’s proxy materials on Schedule 14A outline proposals for stockholder approval, including amendments to the articles of incorporation and bylaws, increases in authorized common stock, authorization of preferred stock, adoption of a treasury reserve strategy, approval of potential future issuances of common stock or convertible securities, and adoption of equity incentive plans. These documents provide insight into the company’s capital structure and governance framework.
On Stock Titan, AI-generated summaries highlight the main points from each filing, helping readers quickly understand topics such as segment disclosures, financing terms, listing status, and board changes. Real-time updates from EDGAR ensure that new LSH filings, including Forms 10-K, 10-Q, 8-K, DEF 14A, and any insider transaction reports on Form 4, are accessible as soon as they are available, with plain-language explanations to support deeper research into Lakeside’s logistics and pharmaceutical distribution businesses.
Lakeside Holding Limited is asking stockholders to approve several major corporate actions at its 2026 virtual annual meeting. Stockholders will vote on electing five directors, increasing authorized common stock from 200,000,000 to 2,000,000,000 shares, creating a new class of up to 1,000,000,000 shares of blank check preferred stock, and lowering supermajority voting thresholds in the Articles of Incorporation. As of the January 5, 2026 record date, 34,427,559 common shares were outstanding, with one vote per share. The agenda also includes ratifying a private placement of 5,600,000 common shares at $0.14 per share for gross proceeds of $784,000 and approving the sale of all shares of subsidiary American Bear Logistics Corp. for $1.00, with the buyer assuming all of that subsidiary’s liabilities. Each proposal has its own required approval level, with the capital-structure and voting-threshold changes needing 75% of voting power.
Lakeside Holding Limited reported that it received a notice from Nasdaq on January 7, 2026 for failing to meet the minimum bid price requirement of
Lakeside Holding Limited reports results for the three months ended September 30, 2025, with total revenue of $6,099,889, up from $4,081,554 a year earlier, driven by growth in cross-border airfreight and new pharmaceutical distribution sales. Gross profit more than doubled to $1,108,767, but operating expenses rose to $2,380,391, leaving a loss from operations of $1,271,624.
Net loss was $1,357,216, similar to the prior period’s $1,335,407, and basic and diluted loss per share improved to $0.09 from $0.18 due to a larger share count. Cash used in operating activities increased to $4,016,518, while financing inflows of $3,672,316, including a $3,000,000 private placement and new loans, helped support liquidity.
Total assets rose to $18,635,189 and equity to $6,954,330 as of September 30, 2025, reflecting share issuances for consulting services, conversion of convertible notes, and the private placement. Loans payable increased to $2,419,103, and the company continues to rely on bank and third-party borrowings alongside equity financing to fund expansion and working capital.
Lakeside Holding Ltd (LSH) filed an initial insider ownership report on Form 3 for director Aik Siang Goh. The filing states that the reporting person currently has no securities beneficially owned in Lakeside Holding Ltd, and the tables for both non-derivative and derivative securities show no holdings. This establishes a formal record of the director’s ownership status as of the reported event date of 11/18/2025.
Lakeside Holding Ltd (LSH) director and Chief Operating Officer Yang Li filed an initial ownership report on Form 3. The filing states that no securities of Lakeside Holding Ltd are beneficially owned at this time. This means the executive currently reports no direct or indirect ownership of the company’s securities as of the event date of 11/18/2025.
Lakeside Holding Limited filed a Form 12b-25, notifying a late Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company states it needs additional time to complete certain disclosures and that timely filing would have caused undue hardship and expense, in part due to circumstances referenced in Part IV.
The company expects to file the Form 10-Q on or before the fifth calendar day following the prescribed due date. The notification lists Long Yi as the contact and was signed by Long Yi, Chief Financial Officer (Principal Executive Officer).
Lakeside Holding Limited called a virtual special meeting on November 25, 2025 to seek stockholder approvals for major capital and governance changes. Proposals include increasing authorized common stock to 2,000,000,000 shares and authorizing 1,000,000,000 shares of blank check preferred. The Board also seeks to amend voting thresholds in the Articles to a simple majority and permit name changes without a stockholder vote, and to amend the Bylaws to reduce the quorum to one‑third of outstanding shares.
The agenda requests approval of a Treasury Reserve Strategy to hold Bitcoin and Ethereum, each capped so the Company’s total holdings do not exceed 5% of that cryptocurrency’s market capitalization at acquisition. It also asks approval under Nasdaq Rule 5635(d) for potential non‑public issuances of common stock and/or convertibles at not less than 80% of the Minimum Price, up to 100,000,000 shares and up to
Lakeside Holding Limited called a special meeting to seek approval for major corporate actions, including raising authorized common stock to 2,000,000,000 shares, creating a class of blank check preferred stock, and a potential company name change. The Board also proposes lowering certain voting thresholds and reducing the meeting quorum to one-third of shares entitled to vote.
The agenda includes a new Treasury Reserve Strategy adopting Bitcoin and Ethereum as primary treasury assets, with each capped at a 5% threshold of that cryptocurrency’s total market capitalization at time of acquisition. The Company also asks to pre‑approve non‑public issuances under Nasdaq Rule 5635(d) of up to 100,000,000 shares (and related convertibles) for up to $100,000,000 in aggregate gross proceeds, and a 2025 Equity Incentive Plan covering 5,000,000 shares. Shares outstanding were 17,427,559 as of October 16, 2025.
Lakeside Holding (LSH) filed its annual report, highlighting a shift to a two-segment model and a challenging year. Total revenue was $17.8 million, down 2.9% year over year, as cross-border freight solutions fell 17.9% amid U.S. trade policy changes and softer demand. The company added a new line in December 2024, generating $2.8 million from pharmaceutical distribution.
Gross profit was $2.9 million (16.2% margin) versus $3.7 million (20.3%) last year, reflecting margin compression in freight (8.8% vs. 20.3%). Pharma posted a 56.1% gross margin, aided by supplier discounts as a new customer. Operating costs rose sharply—selling expenses increased with launch marketing, and G&A climbed 79.1%—driving a net loss of $5.25 million versus a $0.23 million loss a year ago. Interest expense increased 271.5%.
Liquidity at year-end included $5.0 million in cash, a current ratio of 1.06:1, positive working capital of $0.6 million, and $2.8 million in stockholders’ equity. Shares outstanding were 17,427,559 as of October 10, 2025. Management cites tariff uncertainty and de minimis changes as headwinds while scaling the pharma segment.
Lakeside Holding Limited reported changes to its Board of Directors. On September 30, 2025, the Board accepted the resignation of director Ms. Yiye Zhou, effective immediately, and stated that her departure was not due to any disagreement with the company’s operations, policies, or practices.
On the same date, the Board elected Mr. Aik Siang Goh, a technology-focused entrepreneur and executive with over two decades of experience, to serve as a director. Mr. Goh has held senior roles at companies including EdgeMatrix Computing, Chuang House Capital, Amazon Web Services, Fosun Group, Hewlett Packard Enterprise, Dell, and HP. The Board determined that he is an independent director, an “audit committee financial expert,” and a “Non-Employee Director” under applicable Nasdaq and SEC rules.
Mr. Goh will serve on the Audit Committee, the Compensation Committee, and as both a member and chair of the Nominating and Corporate Governance Committee. His compensation will match that of other non-employee directors, and the company reports no related party transactions with him requiring disclosure.